Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients

Clinical trial NCT02829385 · UNKNOWN

Trial details

NCT number: NCT02829385
Sponsor: Shoucheng Ma
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2016-06-01
Primary completion: 2017-12-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.